Retaglutide is a novel GLP-1 receptor agonist currently under research for the management of type 2 diabetes. This medication works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://joanftaj117346.atualblog.com/45552843/trelaglutide-exploring-a-new-therapy-for-chronic-diseases